T. Rowe Price Associates’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,160	Closed	-$18.4M	–	2559
2015 Q1	$18.4M	Sell	2,160 -294	-12%	-$2.51M	﹤0.01%	1162
2014 Q4	$21.6M	Buy	2,454 +217	+10%	+$1.91M	﹤0.01%	1093
2014 Q3	$10.5M	Buy	+2,237	New	+$10.5M	﹤0.01%	1294